Market Research Logo

Percutaneous Transluminal Angioplasty Balloons - Medical Devices Pipeline Assessment, 2016

Percutaneous Transluminal Angioplasty Balloons - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, “Percutaneous Transluminal Angioplasty Balloons - Medical Devices Pipeline Assessment, 2016 provides an overview of Percutaneous Transluminal Angioplasty Balloons currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Percutaneous Transluminal Angioplasty Balloons pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Percutaneous Transluminal Angioplasty Balloons under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Percutaneous Transluminal Angioplasty Balloons and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Percutaneous Transluminal Angioplasty Balloons under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Percutaneous Transluminal Angioplasty Balloons Overview
3 Products under Development
3.1 Percutaneous Transluminal Angioplasty Balloons - Pipeline Products by Stage of Development
3.2 Percutaneous Transluminal Angioplasty Balloons - Pipeline Products by Territory
3.3 Percutaneous Transluminal Angioplasty Balloons - Pipeline Products by Regulatory Path
3.4 Percutaneous Transluminal Angioplasty Balloons - Pipeline Products by Estimated Approval Date
3.5 Percutaneous Transluminal Angioplasty Balloons - Ongoing Clinical Trials
4 Percutaneous Transluminal Angioplasty Balloons - Pipeline Products under Development by Companies
4.1 Percutaneous Transluminal Angioplasty Balloons Companies - Pipeline Products by Stage of Development
4.2 Percutaneous Transluminal Angioplasty Balloons - Pipeline Products by Stage of Development
5 Percutaneous Transluminal Angioplasty Balloons Companies and Product Overview
5.1 Andramed GmbH Company Overview
5.1.1 Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.2 Arravasc Limited Company Overview
5.2.1 Arravasc Limited Pipeline Products & Ongoing Clinical Trials Overview
5.3 Boston Scientific Corporation Company Overview
5.3.1 Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.4 Contego Medical, LLC Company Overview
5.4.1 Contego Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.5 MicroPort Scientific Corporation Company Overview
5.5.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.6 Occlutech International AB Company Overview
5.6.1 Occlutech International AB Pipeline Products & Ongoing Clinical Trials Overview
5.7 QT Vascular Ltd. Company Overview
5.7.1 QT Vascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.8 SurModics, Inc. Company Overview
5.8.1 SurModics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.9 Terumo Corporation Company Overview
5.9.1 Terumo Corporation Pipeline Products & Ongoing Clinical Trials Overview
6 Percutaneous Transluminal Angioplasty Balloons- Recent Developments
6.1 May 11, 2016: Teleflex Raises USD400 Million in Public Offering of 4.875% Notes Due 2026
6.2 Apr 21, 2016: AV Medical Announces Successful Completion of 30 Patient Study with its Innovative Angioplasty Balloon Catheter, Chameleon
6.3 Apr 13, 2016: STENTYS Reports 38% Increase in Revenues in First Quarter 2016
6.4 Mar 16, 2016: STENTYS Reports 2015 Annual Results
6.5 Feb 19, 2016: Nipro Medical Corporation launches the Cronus HP 0. OTW PTA Balloon Catheter in the United States
6.6 Feb 12, 2016: Stentys Raises USD14.3 Million in Rights Offering of Shares
6.7 Feb 09, 2016: New Real-World Comparison Showing Similar Efficacy Between the Lutonix and In.Pact Drug-Coated Balloons Featured at LINC 2016
6.8 Jan 26, 2016: Contego Medical Announces Positive Clinical Data for Paladin System, the First Post-Dilation Balloon with Integrated Embolic Protection Technology
6.9 Jan 13, 2016: STENTYS Reports 81% Year-over-Year Growth in Fourth-Quarter 2015 Revenues
6.10 Jan 11, 2016: SurModics Acquires NorMedix for USD14 Million
6.11 Jan 04, 2016: NuCryo Vascular Gets FDA 510(k) Approval For Next-generation Cryoplasty Inflation Device
6.12 Dec 28, 2015: Registration of Dongguan Kewei Occluder Series Products in Kazakhstan Approved
6.13 Dec 23, 2015: MicroPort Completed the First Distant Interactive Surgery in the Field of Coronary Interventional Treatment
6.14 Dec 02, 2015: MicroPort Orthopedics Attend the Tenth Session of the COA International Conference
6.15 Nov 03, 2015: Additional First Time Endovascular Clinical Trial Results Announced At VIVA15
6.16 Oct 15, 2015: STENTYS Reports 84% Growth in Third-Quarter 2015 Revenues
6.17 Oct 12, 2015: Lutonix Global Real-World Registry Outcomes Presented at TCT 2015
6.18 Sep 30, 2015: QT Vascular Announces Positive Outcome in Spectranetics/AngioScore Patent Trial
6.19 Sep 17, 2015: STENTYS Reports First Half 2015 Financial Results
6.20 Sep 09, 2015: MicroPort Scientific Corporation Announce Leadership Changes in MicroPort Orthopedics Subsidiary and Membership Changes in CEC, IEC
6.21 Sep 01, 2015: MPSC New COO Appointment - Jason Zhang
6.22 Aug 31, 2015: Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference
6.23 Aug 03, 2015: CMS Approves Add-on Payment for Lutonix Drug-Coated Balloon for Inpatient Use
6.24 Jul 14, 2015: QT Vascular Announces The Allowance Of Four New Patents
6.25 Jul 08, 2015: QT Vascular - AngioScore Litigation Additional Updates
6.26 Jul 08, 2015: STENTYS Reports 40% Increase in Revenues in Second Quarter of 2015
6.27 Jun 24, 2015: Spectranetics Receives FDA 510(k) Clearance for Larger Diameter AngioSculpt Scoring Balloon Enabling Entry Into New Markets
6.28 Jun 24, 2015: Premier showcases medical innovations designed to improve patient care
6.29 Jun 02, 2015: Re-inflating balloon after carotid stenting appears to double risk of stroke and death
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Percutaneous Transluminal Angioplasty Balloons - Pipeline Products by Stage of Development
Table 2: Percutaneous Transluminal Angioplasty Balloons - Pipeline Products by Territory
Table 3: Percutaneous Transluminal Angioplasty Balloons - Pipeline Products by Regulatory Path
Table 4: Percutaneous Transluminal Angioplasty Balloons - Pipeline Products by Estimated Approval Date
Table 5: Percutaneous Transluminal Angioplasty Balloons - Ongoing Clinical Trials
Table 6: Percutaneous Transluminal Angioplasty Balloons Companies - Pipeline Products by Stage of Development
Table 7: Percutaneous Transluminal Angioplasty Balloons - Pipeline Products by Stage of Development
Table 8: Andramed GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Zero-Profile PTA Balloon - Product Status
Table 10: Zero-Profile PTA Balloon - Product Description
Table 11: Arravasc Limited Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Pirouette 014 PTA Catheter - Product Status
Table 13: Pirouette 014 PTA Catheter - Product Description
Table 14: Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Next Generation 0.018” Balloon - Product Status
Table 16: Next Generation 0.018” Balloon - Product Description
Table 17: Contego Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 18: PALADIN - Product Status
Table 19: PALADIN - Product Description
Table 20: Superficial Femoral Artery Balloon - Product Status
Table 21: Superficial Femoral Artery Balloon - Product Description
Table 22: Contego Medical, LLC - Ongoing Clinical Trials Overview
Table 23: PALADIN - Multi-center Study to Evaluate Acute Safety and Clinical Performance of Paladin Carotid Post-dilation Balloon with Integrated Embolic Protection
Table 24: MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Reewarm14 - Product Status
Table 26: Reewarm14 - Product Description
Table 27: Reewarm18 Peripheral Balloon Dilation Catheter - Product Status
Table 28: Reewarm18 Peripheral Balloon Dilation Catheter - Product Description
Table 29: Occlutech International AB Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Occlutech Sizing Balloon - Product Status
Table 31: Occlutech Sizing Balloon - Product Description
Table 32: QT Vascular Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Chocolate PTA Balloon Catheter - Product Status
Table 34: Chocolate PTA Balloon Catheter - Product Description
Table 35: QT Vascular Ltd. - Ongoing Clinical Trials Overview
Table 36: Chocolate PTA Balloon Catheter - Chocolate Balloon Angioplasty Registry (Chocolate BAR)
Table 37: Chocolate PTA Balloon Catheter - Procedural Success Assessment After Treatment With Drug Coated Chocolate Balloon
Table 38: SurModics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 39: 0.018” OTW Dual Lumen PTA Catheter - Product Status
Table 40: 0.018” OTW Dual Lumen PTA Catheter - Product Description
Table 41: 0.018” RX Dual Lumen PTA Catheter - Product Status
Table 42: 0.018” RX Dual Lumen PTA Catheter - Product Description
Table 43: 0.035” Large Diameter OTW PTA Catheter - Product Status
Table 44: 0.035” Large Diameter OTW PTA Catheter - Product Description
Table 45: 0.035” Next Generation Workhorse PTA Catheter - Product Status
Table 46: 0.035” Next Generation Workhorse PTA Catheter - Product Description
Table 47: Terumo Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 48: PTA Balloon Catheter - Above Knee - Product Status
Table 49: PTA Balloon Catheter - Above Knee - Product Description
Table 50: Glossary
1.2 List of Figures
Figure 1: Percutaneous Transluminal Angioplasty Balloons - Pipeline Products by Stage of Development
Figure 2: Percutaneous Transluminal Angioplasty Balloons - Pipeline Products by Territory
Figure 3: Percutaneous Transluminal Angioplasty Balloons - Pipeline Products by Regulatory Path
Figure 4: Percutaneous Transluminal Angioplasty Balloons - Pipeline Products by Estimated Approval Date
Figure 5: Percutaneous Transluminal Angioplasty Balloons - Ongoing Clinical Trials

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report